Venom-Derived Peptides in Medicine

Animal venoms represent one of nature's richest pharmacopoeias, containing hundreds to thousands of bioactive peptides evolved over millions of years for prey capture and defense.

Why Venom Peptides Are Special

Evolutionary Optimization - Millions of years of selection for: - High potency (receptor binding) - Target specificity - Stability (must work rapidly) - Result: Drug-like properties

Chemical Features - Typically 10-80 amino acids - Rich in disulfide bonds (stability) - Constrained structures (specificity) - Often resistant to proteases

Major Venom Sources

Snake Venoms **Example: Captopril (ACE inhibitor)** - Derived from Brazilian pit viper (Bothrops jararaca) - Bradykinin-potentiating peptides in venom - Led to billion-dollar antihypertensive class - Original peptide modified to small molecule

Cone Snail Venoms (Conotoxins) **Example: Ziconotide (Prialt®)** - From Conus magus (magician cone) - 25 amino acids, 3 disulfide bonds - Blocks N-type calcium channels - Used for severe chronic pain - Intrathecal delivery required

Each cone snail produces 100-200 unique peptides ("conotoxins")

Gila Monster Venom **Example: Exenatide (Byetta®)** - GLP-1 analog from Heloderma suspectum - 39 amino acids, 53% homology to human GLP-1 - Resistant to DPP-IV degradation - First-in-class GLP-1 agonist for diabetes

Spider Venoms - Source of ion channel modulators - Psalmotoxin (acid-sensing channel blocker) - In development for pain, cardiovascular disease

Scorpion Venoms - Chlorotoxin targets chloride channels - Being developed for brain tumor imaging/treatment - Tumor Paint® (fluorescent chlorotoxin conjugate)

Venom-Derived Drugs

Peptide Classes in Venoms

Ion Channel Toxins - **Conotoxins** — Ca²⁺, Na⁺, K⁺ channels - **Dendrotoxins** — K⁺ channels (mamba snakes) - **Scorpion toxins** — Na⁺, K⁺ channels

Receptor Modulators - GLP-1 agonists (exendin) - Nicotinic receptor antagonists - Muscarinic modulators

Enzyme Inhibitors - Metalloprotease inhibitors - Serine protease inhibitors - Phospholipase inhibitors

From Venom to Drug

Discovery Pipeline 1. **Collection** — Milk venom from animals 2. **Fractionation** — Separate components 3. **Activity screening** — Test for biological activity 4. **Sequencing** — Identify peptide structure 5. **Optimization** — Modify for drug-like properties 6. **Clinical development** — Safety and efficacy trials

Modern Approaches - **Transcriptomics** — Sequence venom gland mRNA - **Proteomics** — Mass spec analysis of venom - **Synthetic biology** — Recombinant production